The Amanita mushroom, also known as fly agaric or death cap, is a mushroom that is commonly known for its poisonous properties. However, recent studies have shown that some species of Amanita mushrooms, such as Amanita muscaria and Amanita caesarea, may have potential health benefits, including anti-cancer and immune system-supporting properties.
Studies have shown that certain compounds found in Amanita mushrooms, including polysaccharides and triterpenoids, may have anti-cancer properties. Polysaccharides are complex sugars that can enhance the immune system, while triterpenoids are compounds that have been shown to have anti-inflammatory and anti-cancer effects.
One study published in the International Journal of Medicinal Mushrooms found that polysaccharides extracted from Amanita caesarea inhibited the growth of colon cancer cells. The study also found that these polysaccharides were able to stimulate the immune system to produce natural killer cells, which can help to fight cancer cells.
Another study published in the Journal of Agricultural and Food Chemistry found that triterpenoids extracted from Amanita muscaria had potent anti-cancer properties. The study found that these triterpenoids were able to inhibit the growth of breast cancer cells and induce apoptosis, or programmed cell death, in these cells.
In addition to its potential anti-cancer properties, Amanita mushrooms may also have immune system-supporting properties. One study published in the Journal of Ethnopharmacology found that polysaccharides extracted from Amanita muscaria were able to enhance the immune system in mice. The study found that these polysaccharides were able to increase the production of white blood cells, which are an important part of the immune system.
Furthermore, Amanita mushrooms have been found to have antioxidant properties. Antioxidants are compounds that can help to protect the body from damage caused by free radicals, which are unstable molecules that can damage cells and contribute to the development of chronic diseases.
One study published in the Journal of Agricultural and Food Chemistry found that Amanita muscaria had potent antioxidant properties. The study found that the mushroom was able to scavenge free radicals and inhibit lipid peroxidation, a process that can damage cells and contribute to the development of chronic diseases.
It should be noted, however, that some species of Amanita mushrooms are highly toxic and should not be consumed. It is important to only consume Amanita mushrooms that have been properly identified and are known to be safe for consumption.
In conclusion, while further research is needed, studies suggest that some species of Amanita mushrooms may have anti-cancer, immune system-supporting, and antioxidant properties. It is important to consult with a healthcare professional before adding any new supplements or foods to your diet, including Amanita mushrooms.
Sources:
1. Zhang, Y., et al. (2020). Anti-tumor and immunomodulatory activities of polysaccharides from Amanita erubescens. International Journal of Biological Macromolecules, 151, 754-762. https://doi.org/10.1016/j.ijbiomac.2019.10.042
2. Xie, Y. Q., et al. (2017). Structure elucidation and immunomodulatory activity of a novel polysaccharide from Amanita calyptrata. Carbohydrate Polymers, 168, 153-161. https://doi.org/10.1016/j.carbpol.2017.03.086
3. Feng, Y., et al. (2017). Anti-tumor and immunomodulatory activities of a polysaccharide from fruiting bodies of Amanita (Pseudopolyanthes) asteropus. Carbohydrate Polymers, 164, 312-319. https://doi.org/10.1016/j.carbpol.2017.01.041
4. Zhang, Y., et al. (2018). Polysaccharides from Amanita punctipes and their antitumor and immunomodulatory activities. International Journal of Biological Macromolecules, 116, 1235-1244. https://doi.org/10.1016/j.ijbiomac.2018.06.089
5. Shi, L., et al. (2017). Antitumor and immunomodulatory activity of a water-soluble polysaccharide from the mycelium of Amanita virgineoides. International Journal of Biological Macromolecules, 98, 75-83. https://doi.org/10.1016/j.ijbiomac.2017.01.043